Biodexa Pharmaceuticals (BDRX) Stock Price, Quote, News & History

Biodexa Pharmaceuticals PLC (BDRX) Stock Price, Quote, News & History

BDRXNASDAQ

Trade with Public

$0.8310

-0.0359-4.14%

At close: Mar 13, 5:00 PM EST

$0.8300

-0.001-0.12%

After Hours: Mar 13, 4:07 PM EST

Key Statistics

Open

$0.87

$0.83

Volume / Avg.

67.45K / 637.78K

Day Range

$0.82 - $0.87

52 Wk Range

0.81 - 26.50

Market Cap

$696.19K

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

5.06%

Days to Cover

Recent Biodexa Pharmaceuticals PLC News

PRO
Biodexa Pharmaceuticals Adds New Phase 1 Ready Candidate To Its Portfolio To Treat Gastrointestinal Stromal Tumors

Biodexa Pharmaceuticals PLC (NASDAQ:BDRX), a clinical-stage biopharmaceutical company developing a pipeline of innovative products for the treatment of rare diseases with an increasing focus on products to treat or

Benzinga Newsdesk

12 Health Care Stocks Moving In Friday's Pre-Market Session

Benzinga Insights

PRO
Biodexa Licenses Otsuka Molecular Glue OPB-171775 For GIST, Plans Phase 1-Ready Candidate MTX240 With Global Rights Ex-Japan

Benzinga Newsdesk

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Key Statistics

Open

$0.87

$0.83

Volume / Avg.

67.45K / 637.78K

Day Range

$0.82 - $0.87

52 Wk Range

0.81 - 26.50

Market Cap

$696.19K

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

5.06%

Days to Cover

About

Sector

Health Care

Industry

Biotechnology

Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder ca...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Biodexa Pharmaceuticals (BDRX) stock?

You can purchase shares of Biodexa Pharmaceuticals (NASDAQ:BDRX) through any online brokerage.

View our list of the best stock brokerages

Who are Biodexa Pharmaceuticals (BDRX) competitors?

Other companies in Biodexa Pharmaceuticals’s space includes: Bone Biologics Corp (NASDAQ:BBLG), AIM ImmunoTech Inc (AMEX:AIM), Ernexa Therapeutics Inc (NASDAQ:ERNAW), Bio Green Med Solution Inc (NASDAQ:BGMSP) and Estrella Immunopharma Inc (NASDAQ:ESLAW).

What is the forecast, or price target, for Biodexa Pharmaceuticals (BDRX) stock?

Biodexa Pharmaceuticals has a consensus price target of $8.00.

What is the current price for Biodexa Pharmaceuticals (BDRX)?

The stock price for Biodexa Pharmaceuticals (NASDAQ: BDRX) is $0.83 last updated March 13, 2026 at 4:07 PM EDT.

Does Biodexa Pharmaceuticals (BDRX) pay a dividend?

There are no upcoming dividends for Biodexa Pharmaceuticals.

When is Biodexa Pharmaceuticals (NASDAQ:BDRX) reporting earnings?

Biodexa Pharmaceuticals does not have any upcoming earnings scheduled.

Is Biodexa Pharmaceuticals (BDRX) going to split?

There is no upcoming split for Biodexa Pharmaceuticals.

What sector and industry does Biodexa Pharmaceuticals (BDRX) operate in?

Biodexa Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

AIM

ERNAW

Bio Green Med Solution Inc

NASDAQ:BGMSP

$2.73

No data available

Estrella Immunopharma Inc

NASDAQ:ESLAW

$0.11

No data available

AZTR

Scinai Immunotherapeutics Ltd

Key Statistics

Open

$0.87

$0.83

Volume / Avg.

67.45K / 637.78K

Day Range

$0.82 - $0.87

52 Wk Range

0.81 - 26.50

Market Cap

$696.19K

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

5.06%

Days to Cover

Recent Biodexa Pharmaceuticals PLC News

PRO
Biodexa Pharmaceuticals Adds New Phase 1 Ready Candidate To Its Portfolio To Treat Gastrointestinal Stromal Tumors

Benzinga Newsdesk

12 Health Care Stocks Moving In Friday's Pre-Market Session

Benzinga Insights

PRO
Biodexa Licenses Otsuka Molecular Glue OPB-171775 For GIST, Plans Phase 1-Ready Candidate MTX240 With Global Rights Ex-Japan

Benzinga Newsdesk

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Key Statistics

Open

$0.87

$0.83

Volume / Avg.

67.45K / 637.78K

Day Range

$0.82 - $0.87

52 Wk Range

0.81 - 26.50

Market Cap

$696.19K

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

5.06%

Days to Cover

About

Sector

Health Care

Industry

Biotechnology

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry